The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 07, 2021

Filed:

Apr. 21, 2016
Applicant:

North Carolina State University, Raleigh, NC (US);

Inventors:

Zhen Gu, Apex, NC (US);

Jicheng Yu, Raleigh, NC (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/44 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61P 3/10 (2006.01); A61K 38/28 (2006.01); A61K 9/51 (2006.01); A61M 37/00 (2006.01); A61K 9/107 (2006.01);
U.S. Cl.
CPC ...
A61K 38/44 (2013.01); A61K 9/0021 (2013.01); A61K 9/0024 (2013.01); A61K 9/1075 (2013.01); A61K 9/5161 (2013.01); A61K 9/5192 (2013.01); A61K 9/7023 (2013.01); A61K 38/28 (2013.01); A61M 37/0015 (2013.01); A61P 3/10 (2018.01); C12Y 101/03004 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0046 (2013.01); A61M 2207/00 (2013.01);
Abstract

A closed-loop insulin delivery system is described. More particularly, the presently disclosed insulin delivery system can comprise glucose-responsive vesicles that release insulin in response to hypoxia triggered by enzymatic reduction of glucose. In addition or as an alternative to insulin, the delivery system can release other diabetes treatment agents, such as non-insulin-based diabetes treatment agents. The vesicles can be prepared from a hypoxia sensitive polymer, such as a hypoxia-sensitive hyaluronic acid (HS-HA). The HS-HA can comprise hydrophobic groups that can be reduced in hypoxic environments to form hydrophilic groups. The vesicles can be loaded into microneedles and microneedle array patches for use in the treatment of diabetes or to otherwise regulate blood glucose levels in subjects in need of such treatment.


Find Patent Forward Citations

Loading…